AU2003243153A8 - Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof - Google Patents

Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof

Info

Publication number
AU2003243153A8
AU2003243153A8 AU2003243153A AU2003243153A AU2003243153A8 AU 2003243153 A8 AU2003243153 A8 AU 2003243153A8 AU 2003243153 A AU2003243153 A AU 2003243153A AU 2003243153 A AU2003243153 A AU 2003243153A AU 2003243153 A8 AU2003243153 A8 AU 2003243153A8
Authority
AU
Australia
Prior art keywords
olanzapine
preparation
polymorph form
crystalline polymorph
novel crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003243153A
Other versions
AU2003243153A1 (en
Inventor
Buchi Reddy Reguri
Ramesh Chakka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of AU2003243153A8 publication Critical patent/AU2003243153A8/en
Publication of AU2003243153A1 publication Critical patent/AU2003243153A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU2003243153A 2002-04-23 2003-04-22 Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof Abandoned AU2003243153A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN311/MAS/2002 2002-04-23
IN311CH2002 2002-04-23
PCT/US2003/012414 WO2003091260A1 (en) 2002-04-23 2003-04-22 Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof

Publications (2)

Publication Number Publication Date
AU2003243153A8 true AU2003243153A8 (en) 2003-11-10
AU2003243153A1 AU2003243153A1 (en) 2003-11-10

Family

ID=29266772

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003243153A Abandoned AU2003243153A1 (en) 2002-04-23 2003-04-22 Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof

Country Status (2)

Country Link
AU (1) AU2003243153A1 (en)
WO (1) WO2003091260A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300324A1 (en) 2002-12-24 2004-07-22 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
US6348458B1 (en) * 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
SK2502003A3 (en) * 2000-08-31 2004-03-02 Reddys Lab Ltd Dr Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
US6740753B2 (en) * 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification

Also Published As

Publication number Publication date
AU2003243153A1 (en) 2003-11-10
WO2003091260A9 (en) 2004-06-03
WO2003091260A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
HK1075044A1 (en) Crystalline polymorphic form of irinotecan hydrochloride
PL378128A1 (en) A process of preparing imatinib and imatinib prepared thereby
SI1488790T1 (en) Solid preparation containing a single crystal a form of a thiazolecarboxylic acid derivative
HUP0300875A3 (en) Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
IL164155A (en) Method for the preparation of crystalline quetiapine hemifumarate form i
EP1463711A4 (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
AU2003251247A1 (en) Methods for preparation of olanzapine polymorphic form i
ZA200401806B (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2003230195A1 (en) A novel process for amorphous form of donepezil hydrochloride
AU2003292452A1 (en) A process for the preparation of a pharmaceutically pure polymorphic form i of olanzapine
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
EP1547993A4 (en) Process for preparation of spirofluorenols
IL163520A0 (en) Process for preparing crystalline form i of cabergoline
AU2003243153A8 (en) Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
AU2003260813A8 (en) Improved process for preparation of thiazolidinedione derivatives
IL163779A0 (en) Process for preparing crystalline form i of cabergoline
HUP0103702A3 (en) Polymorphic crystalline forms of 1-pyrrole derivatives and process for their preparation
AU2003250086A1 (en) Crystalline polymorphic and amorphous forms of benazepril hydrochloride
AU2003262928A8 (en) Crystalline form of nateglinide and process for preparation thereof
AU2003249565A8 (en) Process for production of highly pure donepezil hydrochloride
EP1539772A4 (en) Process of making phosphordiamidite compounds
PL376216A1 (en) A process for the preparation of benzo[d]isoxazol-3-yl-methanesulfonic acid and the intermediates thereof
AU2003242982A1 (en) A novel crystalline form of dorzolamide hydrochloride
AU2003274608A1 (en) Process for preparation of polymorphic form of sertraline hydrochloride

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase